View Document Preview and Link
Document Date: 2014-07-01 08:55:43 Open Document File Size: 698,46 KB Share Result on Facebook
Company AbbVie Inc. / / Facility DOSAGE FORMS AND STRENGTHS LUPRON DEPOT / INDICATIONS AND USAGE LUPRON DEPOT / Pregnancy LUPRON DEPOT / LUPRON DEPOT / DOSAGE AND ADMINISTRATION LUPRON DEPOT / Laboratory Test Interactions / Laboratory Tests / Hypersensitivity LUPRON DEPOT / CONTRAINDICATIONS LUPRON DEPOT / Patients LUPRON DEPOT / / IndustryTerm injection site / safety device / Monitor for cardiovascular disease / treatment for patients with prostate cancer / treatment of advanced prostatic cancer / / MedicalCondition headache / seizures / congenital long QT syndrome / vertebral metastases / GI disorders / convulsion / Cellulitis / central nervous system anomalies / urinary disorder / fatigue / Angina / anaphylactic reactions / Hypersensitivity / prostate cancer / Cardiovascular Diseases / Diabetes Hyperglycemia / flu syndrome / respiratory disorder / ureteral obstruction / paralysis / congestive heart failure / Peptic ulcer / Convulsions / joint disorders / pituitary apoplexy / tumors / sudden cardiac death / urinary disorders / advanced prostatic cancer / Dysphagia / hematuria / Carcinogenesis / Hyperglycemia / cerebrovascular disorders / Diabetes / cardiovascular disease / upper respiratory infection / Fever / pain / myocardial infarction / diabetes mellitus / spinal cord compression / epilepsy / depression / Impotence / paresthesia / serious drug-induced liver injury / disorders / central precocious puberty / / Organization 6-Month Administration / 1-Month Administration / DOSAGE AND ADMINISTRATION / FDA / Administration for Injection of LUPRON DEPOT / 4-Month Administration / 3-Month Administration / / / Position Whole General / physician / / Product LUPRON DEPOT / leuprolide acetate / testosterone / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / / SocialTag